Ryman Healthcare Full Year 2025 Earnings: NZ$0.61 loss per share (vs NZ$0.007 profit in FY 2024)

Ryman Healthcare (NZSE:RYM) Full Year 2025 Results

Key Financial Results

• Revenue: NZ$760.7m (up 11% from FY 2024).
• Net loss: NZ$436.8m (down from NZ$4.78m profit in FY 2024).
• NZ$0.61 loss per share (down from NZ$0.007 profit in FY 2024).

We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Ryman Healthcare Earnings Insights

Looking ahead, revenue is forecast to grow 7.1% p.a. on average during the next 3 years, compared to a 7.2% growth forecast for the Healthcare industry in New Zealand.

Performance of the New Zealander Healthcare industry.

The company's shares are down 16% from a week ago.

Risk Analysis

We should say that we've discovered 1 warning sign for Ryman Healthcare that you should be aware of before investing here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.